Private CAM Research Incentives Advocated By White House Commission
This article was originally published in The Tan Sheet
Executive Summary
The White House Commission on Complementary & Alternative Medicine Policy's final report will suggest the federal government provide incentives to stimulate private sector investment in CAM research
You may also be interested in...
Botanical Monographs, Marketing Exclusivity Discussed By IoM Committee
Botanical products should either conform to established monographs or be subjected to clinical trials that prove their safety and efficacy, health policy analyst Rowena Richter said at an IoM Committee meeting on U.S. consumers' use of complementary & alternative medicine held in Washington, D.C. June 30
Botanical Monographs, Marketing Exclusivity Discussed By IoM Committee
Botanical products should either conform to established monographs or be subjected to clinical trials that prove their safety and efficacy, health policy analyst Rowena Richter said at an IoM Committee meeting on U.S. consumers' use of complementary & alternative medicine held in Washington, D.C. June 30
Botanical Monographs, Marketing Exclusivity Discussed By IoM Committee
Botanical products should either conform to established monographs or be subjected to clinical trials that prove their safety and efficacy, health policy analyst Rowena Richter said at an IoM Committee meeting on U.S. consumers' use of complementary & alternative medicine held in Washington, D.C. June 30